NeuBase Therapeutics Inc Industry Updates Friday Transcript
I hope you've been enjoying the first day of MDF's first virtual conference. I'm Allison Formal, the senior science advisor at MDF. Welcome to this special time in our annual conference when our industry partners come together to share updates about their myotonic dystrophy programs in their cutting edge work in the development of different therapeutics.
This is a chance for us to hear directly from our partners about their approach, their process, and their progress. Today, we will hear from Avidity Biosciences; Ionis Pharmaceuticals; Dyne Therapeutics; and NeuBase. (Operator Instructions) Thank you so much for attending the conference. We hope you have a wonderful rest of the meeting. Thank you.
I'd like to thank the organizers for inviting me here today. My name is Art Levin, and I'm the Chief Scientific Officer at Avidity Biosciences. I'd like to talk to you today about antibody oligonucleotide conjugates for the treatment of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
